文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

药物联合研究及其协同作用的定量分析——Chou-Talalay 法

Drug combination studies and their synergy quantification using the Chou-Talalay method.

机构信息

Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

出版信息

Cancer Res. 2010 Jan 15;70(2):440-6. doi: 10.1158/0008-5472.CAN-09-1947. Epub 2010 Jan 12.


DOI:10.1158/0008-5472.CAN-09-1947
PMID:20068163
Abstract

This brief perspective article focuses on the most common errors and pitfalls, as well as the do's and don'ts in drug combination studies, in terms of experimental design, data acquisition, data interpretation, and computerized simulation. The Chou-Talalay method for drug combination is based on the median-effect equation, derived from the mass-action law principle, which is the unified theory that provides the common link between single entity and multiple entities, and first order and higher order dynamics. This general equation encompasses the Michaelis-Menten, Hill, Henderson-Hasselbalch, and Scatchard equations in biochemistry and biophysics. The resulting combination index (CI) theorem of Chou-Talalay offers quantitative definition for additive effect (CI = 1), synergism (CI < 1), and antagonism (CI > 1) in drug combinations. This theory also provides algorithms for automated computer simulation for synergism and/or antagonism at any effect and dose level, as shown in the CI plot and isobologram, respectively.

摘要

这篇简要的观点文章集中讨论了药物联合研究中在实验设计、数据采集、数据解释和计算机模拟方面最常见的错误和陷阱,以及应该做和不应该做的事情。Chou-Talalay 药物联合方法基于中值效应方程,该方程源自质量作用定律原理,这是提供单一实体和多个实体之间以及一阶和更高阶动力学之间共同联系的统一理论。这个通用方程包含了生物化学和生物物理学中的 Michaelis-Menten、Hill、Henderson-Hasselbalch 和 Scatchard 方程。Chou-Talalay 的组合指数(CI)定理为药物联合中的相加效应(CI = 1)、协同作用(CI < 1)和拮抗作用(CI > 1)提供了定量定义。该理论还提供了在任何效应和剂量水平下自动计算机模拟协同作用和/或拮抗作用的算法,分别如图中所示的 CI 图和等效应线图。

相似文献

[1]
Drug combination studies and their synergy quantification using the Chou-Talalay method.

Cancer Res. 2010-1-12

[2]
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies.

Pharmacol Rev. 2006-9

[3]
Drug combination studies and their synergy quantification using the Chou-Talalay method--letter.

Cancer Res. 2015-6-1

[4]
Synergistic combination of microtubule targeting anticancer fludelone with cytoprotective panaxytriol derived from panax ginseng against MX-1 cells in vitro: experimental design and data analysis using the combination index method.

Am J Cancer Res. 2015-12-15

[5]
The mass-action law based algorithms for quantitative econo-green bio-research.

Integr Biol (Camb). 2011-3-14

[6]
Preclinical versus clinical drug combination studies.

Leuk Lymphoma. 2008-11

[7]
Rational approach to the clinical protocol design for drug combinations: a review.

Acta Paediatr Taiwan. 2000

[8]
Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design.

J Natl Cancer Inst. 1994-10-19

[9]
An improved model for the analysis of combined antimicrobials: a replacement for the Chou-Talalay combination index method.

J Appl Microbiol. 2017-12-7

[10]
The mass-action law based algorithm for cost-effective approach for cancer drug discovery and development.

Am J Cancer Res. 2011-8-5

引用本文的文献

[1]
Isodeoxyelephantopin Promotes Cell Death in Triple-Negative Breast Cancer by Blocking STAT3 Phosphorylation and Enhancing the Effectiveness of Paclitaxel.

Food Sci Nutr. 2025-9-5

[2]
Log-probit accompanied with Tallarida and Chou-Talalay-Martin methods in an isobolographic analysis of interactions between two antiseizure medications - a comparative study.

Pharmacol Rep. 2025-9-5

[3]
Silvestrol inhibits nasopharyngeal carcinoma cells and synergizes with CX-5461: Insights from a proteomics study.

Mol Clin Oncol. 2025-8-19

[4]
The synergistic effect of 2-deoxy-D-glucose and cytarabine on mitochondria of stem-like cells derived from KG1-a.

Leuk Res Rep. 2025-8-11

[5]
Combination of WEE1 Inhibitor and Vitamin K2 Enhances Therapeutic Efficacy in Chronic Myeloid Leukemia.

Cancer Innov. 2025-8-28

[6]
Cannabidiol Is Associated with Improved Survival in Pancreatic Cancer and Modulation of Bile Acids and Gut Microbiota.

Int J Mol Sci. 2025-8-10

[7]
Phenanthrene Monomers and Dimers from with Antiproliferative Activity and Synergistic Effect with Doxorubicin Against Human Colon Cancer Cell Lines.

Int J Mol Sci. 2025-8-8

[8]
Water-based propolis enhances 5-fluorouracil drug efficiency in gastric and colorectal cancer cells through cell stress response, anti-migratory, and apoptotic effects regardless of p53 status.

Med Oncol. 2025-8-26

[9]
CDK4/6 inhibitors synergize with radiotherapy to prime the tumor microenvironment and enhance the antitumor effect of anti-PD-L1 immunotherapy in triple-negative breast cancer.

J Biomed Sci. 2025-8-20

[10]
Oncogenic p53 induces mitotic errors in lung cancer cells by recopying DNA replication forks conferring targetable proliferation advantage.

Res Sq. 2025-8-13

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索